Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered to be of potential interest in the treatment of asthma.

There is a need to develop new anti-inflammatory therapies for this disease. This article critically reviews clinical trial data of novel anti-inflammatory drugs in asthma, encompassing specific ...

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in ...